Nebivolol in preventing atrial fibrillation following coronary surgery in patients over 60 years of age

ERDİL N., Kaynak M., Donmez K., DİŞLİ O. M., BATTALOĞLU B.

REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR, vol.29, no.4, pp.581-587, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 29 Issue: 4
  • Publication Date: 2014
  • Doi Number: 10.5935/1678-9741.20140078
  • Journal Name: REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.581-587
  • Keywords: Coronary Artery Bypass, Atrial Fibrillation, Anti-Arrhythmia Agents, Drug Therapy, ARTERY BYPASS-SURGERY, CARDIAC-SURGERY, GRAFT-SURGERY, BETA-BLOCKER, RISK, METAANALYSIS, ATENOLOL, HYPERTENSION, ARRHYTHMIAS, PREDICTORS
  • Inonu University Affiliated: Yes

Abstract

Objective: Postoperative atrial fibrillation is a common complication after cardiac surgery, with an incidence as high as 20-50%. Increased age is associated with a significant increase in postoperative atrial fibrillation risk. This common complication is associated with higher morbidity and mortality rates. The aim of this study was to assess the efficacy of nebivolol in preventing atrial fibrillation following coronary artery bypass surgery in patients over 60 years of age.